Navigating the MIBC Patient

Learning Objectives:

• Describe multimodal therapy for bladder cancer
• Understand the role of neoadjuvant chemotherapy and immunotherapy
• Obtain knowledge of checkpoint inhibitors and antibody drub conjugates
• Review ongoing clinical trial and emerging therapies
• Develop a working understanding of ctDNA and its future uses